Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Zeria

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Zeria's Japan sales performance.

Takeda mulls bid for Irish biopharma Shire

Takeda mulls bid for Irish biopharma Shire

Takeda, Japan’s largest pharmaceutical company by sales, has announced that it’s considering a possible takeover deal for Shire, a biopharma focused on rare diseases.

First blood to Roche in Hemlibra patent fight with Shire

First blood to Roche in Hemlibra patent fight with Shire While the ruling doesn’t have a direct bearing on additional challenges outside Japan, Roche has been buoyed by the result. ... Hemlibra has been approved in the US, Europe and Japan to prevent or reduce the frequency of bleeding episodes in patients

Yale Cancer Center joins BMS’ II-ON

Yale Cancer Center joins BMS’ II-ON Operating under a peer-to-peer approach, the network - which was the first of its kind - has expanded from 10 to 16 sites spanning across North America, Europe, Japan and Australia.

Significant figures

Significant figures Olaf said that ALIS’second NDA filing will most likely be in Japan due to its big NTM population and the regular frequency of physicians testing for NTM disease in patients.

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ()

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics